Drug intelligence / Profile preview

Lidocaine + diphenhydramine

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Lidocaine + diphenhydramine is a combination of two small molecule drugs commonly used topically or as part of compounded preparations to relieve pain and itching associated with inflammatory and allergic skin conditions, as well as oral mucositis. Lidocaine is an amide-type local anesthetic that works by blocking sodium channels on nerve cell membranes, thereby inhibiting the initiation and conduction of nerve impulses, resulting in local anesthesia. Diphenhydramine is a first-generation antihistamine that acts primarily as an antagonist at histamine H1 receptors, reducing symptoms such as pruritus (itching) caused by histamine release during allergic reactions. The combination provides synergistic effects for symptomatic relief in conditions like insect bites, contact dermatitis, jellyfish stings, and mouth sores[2][3][8]. Clinical studies support its efficacy for treating histamine-related skin reactions accompanied by pruritus[2]. The mixture may be found in topical gels or compounded oral rinses (e.g., "magic mouthwash") for mucosal pain management.

02

Targets

HRH1 (Histamine H1 Receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Lidocaine + diphenhydramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lidocaine + diphenhydramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call